Study guide
2.3 Care Planning for Special & High-Risk Patient Populations
Certified Perioperative Nurse CNOR
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Preoperative Assessment & Risk Stratification
1.1 Preoperative Patient History, Physical Assessment & Comorbidity Stratification 1.2 Preoperative Diagnostic Testing, Coagulation Panels & Critical Lab Values 1.3 Preoperative Allergy Screening & Sensitivity Protocols 1.4 Preoperative Fasting (NPO) Guidelines, Medication Management & Patient Education
2 Chapter 2: Plan of Care Development & Postoperative PACU Care
2.1 Perioperative Nursing Data Set (PNDS), Care Planning & Measurable Outcomes 2.2 Surgical Positioning Mechanics, Pressure Injury Prevention & Anatomical Considerations 2.3 Care Planning for Special & High-Risk Patient Populations 2.4 Postoperative PACU Handoffs, Aldrete Scoring & Discharge Readiness
3 Chapter 3: Intraoperative Safety & Surgical Patient Protection
3.1 Universal Protocol, Surgical Site Marking & Time Out Execution 3.2 Surgical Skin Antisepsis, Agent Selection & Draping Principles 3.3 Intraoperative Anesthesia Support, Airway Management & Physiological Monitoring 3.4 Surgical Instrument, Sponge & Sharps Counts and Discrepancy Protocols
4 Chapter 4: Medical Devices, Electrosurgery & Specimen Management
4.1 Monopolar & Bipolar Electrosurgical Unit (ESU) Safety & Dispersive Pad Placement 4.2 Surgical Laser Safety, Wavelength Hazards & Environmental Fire Protection 4.3 Surgical Specimen Handling, Labeling & Tissue Chain of Custody 4.4 Environmental Controls: OR Temperature, Humidity, Pressure & Ventilation Standards
5 Chapter 5: Personnel Management, Communication & Charting
5.1 Intraoperative Team Roles, Delegation & Interprofessional Coordination 5.2 Operating Room Workflow, Supply Management & Lean Operations 5.3 Intraoperative Nursing Documentation Standards & Legal Charting Requirements 5.4 Clinical Handoff Communication (SBAR) & Assertive Safety Protocols (CUS)
6 Chapter 6: Surgical Asepsis, Attire & Environmental Controls
6.1 Principles of Surgical Asepsis, Sterile Field Maintenance & Gowning/Gloving 6.2 Surgical Attire Standards, Scrub Techniques & Traffic Zone Architecture 6.3 Environmental Cleaning, Room Turnover & Terminal Disinfection 6.4 Biohazardous Waste Disposal & Needlestick Exposure Management
7 Chapter 7: Instrument Decontamination, Sterilization & SSI Prevention
7.1 Point-of-Use Instrument Care, Transport & Decontamination Science 7.2 High-Temperature Steam Sterilization & Biological/Chemical Indicator Monitoring 7.3 Low-Temperature Sterilization (ETO & Gas Plasma) & High-Level Disinfection 7.4 Surgical Site Infection (SSI) Prevention Strategies & Glycemic/Normothermia Control
8 Chapter 8: Management of Intraoperative Emergencies
8.1 Malignant Hyperthermia (MH) Pathophysiology, Protocol & Dantrolene Administration 8.2 Surgical Fire Prevention (Fire Triad) & Airway/OR Fire Protocols 8.3 Local Anesthetic Systemic Toxicity (LAST) & Lipid Emulsion (Intralipid) Resuscitation 8.4 Intraoperative Cardiac Arrest, Massive Hemorrhage Protocol (MHP) & Autotransfusion
9 Chapter 9: Professional Standards, Ethics & Exam Preparation
9.1 AORN Guidelines for Perioperative Practice & Evidence-Based Nursing 9.2 Ethical Principles, Informed Consent, DNR Orders & Legal Standards in the OR 9.3 CNOR Exam Structure, Scaled Scoring (620 Target) & Test-Taking Strategies
2.3 Care Planning for Special & High-Risk Patient Populations
Key Takeaways Explain This Topic AI
Neonates and infants rely on non-shivering thermogenesis via brown adipose tissue, requiring ambient OR temperatures of 24°C–26°C (75°F–78°F) to prevent hypoxemia and lactic acidosis.
Pediatric fluid maintenance follows the 4-2-1 rule: 4 mL/kg/hr for the first 10 kg, 2 mL/kg/hr for 11–20 kg, and 1 mL/kg/hr for each kg over 20 kg.
Malignant Hyperthermia (MH) is triggered by volatile anesthetics and succinylcholine, presenting early with unexplained hypercarbia (EtCO2 >50 mmHg) and sinus tachycardia.
Emergency treatment for MH requires immediate cessation of triggers, 100% O2 at >10 L/min, and IV Dantrolene sodium (2.5 mg/kg IV push up to 10 mg/kg total).
Pregnant patients past 20 weeks gestation require 15-degree left uterine displacement (LUD) via a right hip wedge to prevent aortocaval compression and maternal hypotension.
Last updated: July 2026
2.3 Care Planning for Special & High-Risk Patient Populations
Perioperative care planning must be tailored to address the unique physiological, anatomical, and pharmacological vulnerabilities of special patient populations. High-risk groups—including bariatric patients , pediatric patients , geriatric patients , obstetric patients, and individuals susceptible to malignant hyperthermia (MH) —require specialized nursing interventions and clinical protocols to mitigate intraoperative morbidity and mortality.
Bariatric Patient Management (BMI ≥30 kg/m²)
Surgical care for patients classified as obese (BMI 30–39.9 kg/m²), morbidly obese (BMI ≥40 kg/m²), or super-obese (BMI ≥50 kg/m²) presents distinct mechanical and physiological challenges.
Weight Capacity Verification : Perioperative nurses must verify that the operating table, transfer devices, and extensions meet or exceed patient weight requirements. Standard tables accommodate up to 400–500 lbs (181–226 kg) , whereas specialized bariatric tables support up to 1,000 lbs (454 kg) .
Airway & Respiratory Mechanics : Excess adipose tissue on the chest wall and abdomen severely decreases lung compliance and Functional Residual Capacity (FRC).
Position the patient in a ramped position for intubation (aligning the external auditory meatus horizontally with the sternal notch) to improve laryngeal visualization.
Utilize Reverse Trendelenburg with a padded footboard intraoperatively to allow abdominal contents to shift gravitationally away from the diaphragm, enhancing tidal volume.
Obstructive Sleep Apnea (OSA) : Screen all bariatric patients using the STOP-Bang questionnaire . A score ≥5 indicates high risk for severe OSA, requiring continuous postoperative pulse oximetry, capnography, and avoidance of heavy opioid sedation.
Rhabdomyolysis Risk : Prolonged tissue pressure in heavy bariatric procedures (>3 to 4 hours) can cause gluteal and thigh muscle breakdown, releasing myoglobin and causing acute kidney injury. Monitor for dark port-wine urine and elevated creatine kinase (CK).
Pediatric Patient Considerations (Neonates to Adolescents)
Pediatric surgical patients are not small adults; their physiological reserves and anatomical proportions differ fundamentally across developmental stages.
Physiological & Environmental Precautions:
Thermoregulation : Neonates (<28 days) and infants (<1 year) have a large body surface-area-to-mass ratio, thin skin, and minimal subcutaneous fat. They cannot shiver effectively and rely on non-shivering thermogenesis via brown adipose tissue . This metabolic pathway consumes high amounts of oxygen and glucose, predisposing hypothermic infants to severe hypoxemia, metabolic acidosis, and hypoglycemia.
Room Temperature Guardrail : Increase ambient OR temperature to 24°C–26°C (75°F–78°F) for neonates and infants before bringing them into the suite.
Use radiant warmers, warmed irrigation solutions ( 37°C–40°C ), fluid warmers, and inline breathing circuit humidifiers.
Fluid & Medication Calculations : All medications and IV fluid boluses must be strictly weight-based (mg/kg or mL/kg).
Standard pediatric maintenance fluids follow the 4-2-1 rule : 4 mL/kg/hr for the first 10 kg of weight, 2 mL/kg/hr for the next 10 kg (11–20 kg), and 1 mL/kg/hr for each kilogram above 20 kg.
Geriatric Patient Care (Age ≥65 Years)
Aging causes progressive decline in homeostatic reserve across all organ systems.
System Physiological Alteration Clinical Perioperative Intervention
Integumentary Epidermal thinning, loss of subcutaneous fat, decreased turgor High risk for skin tears and shear. Avoid harsh adhesives; use silicone or paper tape; pad all bony prominences.
Pharmacokinetics Decreased renal GFR, reduced hepatic blood flow, reduced serum albumin Reduced Minimum Alveolar Concentration (MAC) requirement by 30%–50% . Prolonged drug half-lives; titrate anesthetics cautiously.
Cardiovascular Arterial stiffness, decreased myocardial compliance, blunted baroreceptor response High risk for sudden fluid overload or hypovolemic hypotension. Monitor fluid balance meticulously.
Neurological Decreased central neurotransmitters, sensory impairment Screen baseline cognitive function. Implement delirium prevention protocols (avoid anticholinergics and benzodiazepines).
Malignant Hyperthermia (MH) Emergency Protocol
Malignant hyperthermia (MH) is a life-threatening, pharmacogenetic disorder of skeletal muscle inherited in an autosomal dominant pattern, primarily caused by mutations in the ryanodine receptor (RYR1) gene.
Triggering Agents:
All volatile anesthetics (isoflurane, sevoflurane, desflurane, halothane).
The depolarizing neuromuscular blocking agent succinylcholine .
Note : Nitrous oxide, IV induction agents (propofol, etomidate, ketamine), local anesthetics, and non-depolarizing relaxants are MH-safe .
Clinical Indicators:
Earliest Clinical Indicators : Rapid rise in end-tidal CO2 ( EtCO2 >50 mmHg ) unresponsive to hyperventilation, unexplained sinus tachycardia , and masseter muscle spasm.
Late Clinical Indicators : Rapidly rising core body temperature ( 1°C–2°C every 5 minutes , reaching >41°C / 105.8°F), severe muscle rigidity, hyperkalemia, myoglobinuria, and disseminated intravascular coagulation (DIC).
Crisis Management Workflow:
Discontinue Triggers Instantly : Alert the surgeon, stop volatile agents and succinylcholine, and call for the MH cart and help.
Hyperventilate : Administer 100% oxygen at maximum flow rates ( >10 L/min ) through a clean circuit to flush out volatile gases.
Administer Dantrolene Sodium :
Dantrolene is the specific antidote that binds RYR1 receptors and halts calcium release.
Standard Formulation (Dantrium/Revonto) : Initial dose 2.5 mg/kg IV push . Each 20 mg vial must be reconstituted with 60 mL of sterile water without a bacteriostatic agent. Repeat IV push doses up to 10 mg/kg total until hypermetabolism subsides.
Concentrated Formulation (Ryanodex) : Initial dose 2.5 mg/kg IV push . Each 250 mg vial is reconstituted with only 5 mL of sterile water, allowing rapid push within seconds.
Cool the Patient : Initiate active cooling with cold IV saline, iced nasogastric/abdominal lavage, and ice packs to axillae, groin, and neck. Stop cooling when core temperature drops below 38.0°C (100.4°F) to prevent iatrogenic hypothermia.
Treat Hyperkalemia & Acidosis : Administer sodium bicarbonate for metabolic acidosis, IV regular insulin with 50% dextrose, and calcium chloride for severe hyperkalemic cardiac dysrhythmias.
Obstetric Patient Considerations (Pregnancy >20 Weeks)
When caring for a pregnant surgical patient past 20 weeks gestation , position the patient with a 15-degree left uterine displacement (LUD) by placing a firm wedge under the right hip. This displaces the heavy gravid uterus off the inferior vena cava and abdominal aorta, preventing aortocaval compression , maternal hypotension, decreased uteroplacental perfusion, and fetal distress.